Oncology PracticeRefractory immune-mediated colitis: Fecal transplant may be the answerNovember 12, 2018Immuno-oncologyGenitourinary CancerRenal Cell CarcinomaPatient & Survivor Care
Oncology PracticeFDA approves second pegfilgrastim biosimilarNovember 2, 2018Patient & Survivor CareBreast Cancer
Hematology NewsNovel risk factors for febrile neutropenia in NHL, solid tumorsNovember 2, 2018Patient & Survivor CareAggressive Lymphomas
The Journal of Community and Supportive OncologyCollaboration is key to bridging the AYA cancer care divideOctober 31, 2018Patient & Survivor CarePediatricsB Cell Lymphoma
Hematology NewsPalliative care update highlights role of nonspecialistsOctober 31, 2018Mixed TopicsPatient & Survivor Care
The Journal of Community and Supportive OncologyGame changers in pediatric cancerOctober 31, 2018Patient & Survivor CarePediatricsB Cell Lymphoma
The Journal of Community and Supportive OncologyProlonged survival in adenocarcinoma of unknown primary treated with chemoradiotherapyOctober 30, 2018Patient & Survivor Care
The Journal of Community and Supportive OncologyMarriage predicts for survival in patients with stage III non–small-cell lung cancerOctober 28, 2018Patient & Survivor Care
The Journal of Community and Supportive OncologyFinding that sweet spot where science, practice, and best-possible outcomes come togetherOctober 28, 2018Patient & Survivor Care
Oncology PracticeNo ADT-dementia link in large VA prostate cancer cohort studyOctober 15, 2018Genitourinary CancerPatient & Survivor CareRenal Cell Carcinoma
Oncology PracticeTech-based cancer company raises access concernsOctober 12, 2018Practice ManagementPatient & Survivor CareBreast CancerGynecologic CancerBusiness of Medicine
Oncology PracticeBeware drug reactions from methotrexate, voriconazole, and BRAF inhibitorsOctober 5, 2018Patient & Survivor Care
Oncology PracticeOpioid use cut nearly 50% for urologic oncology surgery patientsOctober 5, 2018Patient & Survivor CareGenitourinary CancerOpioid Resource Center
